By contrast, in ankylosing spondylitis, we and others observe PD‐1^high CD8+ T cells with low or absent TOX and retained effector function, including clonal expansion at lesion sites, which satisfies our operational criteria for exhaustion resistance [8, 11, 12]. This evidence concerns the gene CD8A and ankylosing spondylitis.